Details of the Optogenetic System
General Information of This Optogenetic System (OS) | ||||||
---|---|---|---|---|---|---|
OS ID |
OS00634
|
|||||
OS Name |
Optogenetic bispecific T-cell engagers
(OptoBiTEs)
|
[1] | ||||
Photoreceptor (PR) |
|
|||||
Cofactor | Biliverdin (BV) | |||||
Controlled Protein | Fusion protein | Putative DNA binding protein | ||||
The bacterial c-di-GMP phosphodiesterase | ||||||
OS Application Information (1) | ||||||
---|---|---|---|---|---|---|
Mechanism of Action | c-di-GMP synthesis | [ 1] | ||||
Controlled Signal Pathway | Gene expression | |||||
Effect | Activation | |||||
Application | Optogenetics can regulate the production of BiTEs from bioengineered cells for the treatment of cancer | |||||
Note | This method could be potentially applied to other formats of bispecific antibodies and facilitate their clinical applications | |||||
Light Information | Activation Wavelength | Far-red Light | ||||
Process | Reversible | |||||
Deactivation Wavelength | Dark | |||||
Activation Time | 24 h | |||||
Light Intensity | 1 miliwatt per square centimeter | |||||
Expression Information | Expression Method | Transfection | ||||
Cell Lines | HEK293FT cells | |||||